Norris Medicines Appoints Vimal Shah as MD for 3 Years

Norris Medicines Limited announced the appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as Managing Director for a term of three years, effective September 1, 2026, until August 31, 2029. This reappointment is subject to shareholder approval. Mr. Shah, a commerce graduate with over 15 years of business management experience, also serves on the Audit Committee and Stakeholders Relationship Committee. The company also reported its un-audited financial results for the quarter ended June 30, 2026, showing a net loss of ₹39.68 lakhs. The Board of Directors approved these results and the appointment during their meeting held on August 14, 2026.